Answers are grounded in this paper and cite their sources.
Following the introduction of the pneumococcal conjugate vaccine, a significant decline was observed in invasive pneumococcal disease caused by vaccine serotypes. However, data on the effectiveness in this region remain scarce, meriting continued surveillance to assess the effectiveness of pneumococcal vaccination to improve protection against invasive pneumococcal disease.
No takes yet. Share an insight, caveat, or question.
Ngocho et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: